|
|
|
| |
|
 |
 |
|
|
|
National Steering Committee (NSC, Chinese side)
Prof. Chunli Bai, Academician,Chinese Academy of Sciences
Prof. Daoben Zhu, Academician,National Science Fundation of China
Prof. Yan Shen, Academician,National Science Fundation of China
Prof. Fuyu Yang, Academician,Institute of Biophysics, CAS
Prof. Yuanfang Liu, AcademicianPeking University
Prof. Zihe Rao, Academician,President of Nankai University
Prof. Xishan Hao, Academician,President of Tianjin Medical University, and Tianjin Cancer Hospital
Prof. Shishen Xie, Academician,Institute of Physics, CAS
Prof. Lihe Zhang, Academician,Medical School, Peking University
Prof. Hesheng Chen, Academician,Inst. of High Energy Physics, CAS
Prof. Zhifang Chai, Academician,Inst. of High Energy Physics, CAS
Prof. Changxiao Liu, Academician,Tianjin Institute of Pharmaceutical Research
Prof. Xian`en Zhang,Ministry of Science and Technology of China
Prof. Yanhe Ma,Ministry of Science and Technology of China
Prof. Wenping Liang,National Natural Science Fundation of China
Prof. Shengming Du,National Natural Science Fundation of China
Prof. Qimin Zhan,Chinese Academy of Medical Sciences
National Steering Committee (NSC, American side)
Dr. Michael M. Gottesman , Deputy Director for Intramural Research of National Institute of Health (NIH)
Chief, Laboratoryof Cell Biology, National Cancer Institute (NCI)
Dr. Samuel H. Wilson, Deputy director of the National Institute of Environmental Health Sciences (NIEHS)
Dr. Sally S. Tinkle. Deputy Director of the National Institute of Environmental Health Sciences (NIEHS)
Dr. Piotr Grodzinski, Director of Nanotechnology for Cancer programs at Nanotechnology Alliance£¬National Cancer Institute (NCI)
Dr. Robert Blumenthal , Chief, Nanobiological Program Division, National Cancer Institute (NCI)
Dr. Anna D. Barker, Deputy Director, Advanced Technologies and Strategic Partnerships, Center of Cancer Nanotechnology Excellence, National Cancer Institute (NCI)
|
| |
|
|
|
